PHYSIOLOGICAL AND PHARMACOLOGICAL BASES FOR THE DIVERSE PROPERTIES OF BENZODIAZEPINES AND THEIR CONGENERS

被引:12
作者
GIUSTI, P
ARBAN, R
机构
[1] Department of Pharmacology, University of Padova, 35131 Padova, Largo Meneghetti
关键词
BENZODIAZEPINES; GABA(A) RECEPTORS; PARTIAL AGONISTS; FULL AGONISTS;
D O I
10.1006/phrs.1993.1019
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Benzodiazepines (BZs), which have been marketed by pharmaceutical companies since the sixties, are the most commonly prescribed psychotropic drugs. Diazepam, the prototype of this class of drugs, has a vast spectrum of therapeutic indications. It possesses, over a narrow dose-range, the well-known neuropsychopharmacological profile consisting of anxiolytic, anticonvulsant, sedative, and muscle relaxant effects, and CNS depression. Recently, BZ ligands that retain anxiolytic and antiepileptic properties at doses that are unable to produce a CNS depression have been developed. The pharmacological profiles of these drugs are discussed in light of: the heterogeneity of the structure of the GABAA receptor complex; intrinsic efficacy of the ligand; action of the BZ ligand on the mitochondrial BZ receptor. © 1993 Academic Press. All rights reserved.
引用
收藏
页码:201 / 215
页数:15
相关论文
共 67 条
[21]   CLINICAL CHOICE OF SEDATIVE-HYPNOTICS [J].
GREENBLATT, DJ ;
SHADER, RI .
ANNALS OF INTERNAL MEDICINE, 1972, 77 (01) :91-+
[22]  
GUIDOTTI A, 1990, ADV BIOCHEM PSYCHOPH, V46, P73
[23]   NOVEL ANXIOLYTICS THAT ACT AS PARTIAL AGONISTS AT BENZODIAZEPINE RECEPTORS [J].
HAEFELY, W ;
MARTIN, JR ;
SCHOCH, P .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (11) :452-456
[24]  
HAEFELY W, 1975, MECHANISM ACTION BEN, P131
[25]  
HERMAN JB, 1987, J CLIN PSYCHOPHARM, V7, P175
[26]   NEUROSTEROIDS - OLIGODENDROCYTE MITOCHONDRIA CONVERT CHOLESTEROL TO PREGNENOLONE [J].
HU, ZY ;
BOURREAU, E ;
JUNGTESTAS, I ;
ROBEL, P ;
BAULIEU, EE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (23) :8215-8219
[27]  
Johnston GA, 1986, RECEPTOR BIOCH METHO, V5, P57
[28]  
KATSCHNIG H, 1989, BIOL PSYCHIATRIE, P167
[29]   ZOLPIDEM - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL [J].
LANGTRY, HD ;
BENFIELD, P .
DRUGS, 1990, 40 (02) :291-313
[30]  
LEEBLUNDBERG F, 1981, J NEUROSCI, V1, P471